Capital M Podcast: KaloCyte President & CEO Elaine Haynes Discusses Business in Maryland

The Capital M Podcast #LifeScienceRevolution: Proximity to Resources with KaloCyte. Listen to part 3 of the Capital M podcast, #LifeScienceRevolution: Proximity to Resources with KaloCyte. In this episode, MTC CEO Martin Rosendale discusses business in Maryland with Elaine E. Hayne, President and CEO of KaloCyte, Inc., a pre-clinical biotech startup developing a synthetic red blood cell substitute. Listen to the […]

Cartesian Initiates CAR-T Clinical Trial in Myasthenia Gravis

First CAR-T to enter clinical development for an autoimmune disease Descartes-08 engineered to have a defined, predictable half-life, enabling repeat dosing to maximize potential for potency while minimizing risk of toxicity Gaithersburg, MD, November 5, 2019 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer and autoimmune diseases, today […]

BioBuzz: Pat Larrabee is Building the Biotech Infrastructure in the Capital Region and has been for Nearly 25 Years – Here’s What’s Next…

The growth of the BioHealth Capital Region (BHCR) and its position as a global biohealth cluster is a hot topic of discussion—often filtered through a broad, conceptual lens focused on big-picture trends, GEN publication rankings and widely discussed areas of industry need. The development and growth of the BHCR is also a story that supports the life […]

BioBuzz: For 20 Years This Company Has Helped to Shape the Field of Cell Therapy

How MaxCyte Has Evolved to Become Leading Technology Provider for Cell Engineering and Leveraged Its Flow Electroporation® Technology and Know-How to Launch Its Own Robust CAR Pipeline MaxCyte, located in Gaithersburg, Maryland, is a unique biotech company that is a key anchor of the robust and growing Maryland cell and gene therapy industry. Founded in 1999, […]

Technical.ly Baltimore: Illumina Opens Training Center at University of Maryland BioPark

The San Diego genomics leader is expecting the facility to host hundreds of customers and employees each year. Illumina’s first East Coast location is officially open in Baltimore. On Tuesday, the San Diego-based genomics leader celebrated the grand opening of its new facility at the University of Maryland BioPark, the 14-acre research and technology park located to […]

Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965

Key milestone reached in adaptive Phase 1/1b clinical trial that began in April 2019 Cambridge, MA, October 21, 2019 – Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and nonalcoholic steatohepatitis (NASH), today announced that the first IPF patient has been […]

CoapTech LLC Awarded $1.2M Grant from National Institutes of Health to Support Clinical Evaluation and Training for Novel PUMA-G Device

BALTIMORE, Md., Oct. 21, 2019 (GLOBE NEWSWIRE) — CoapTech LLC announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded the company a two-year, $1.2M R44 Small Business Innovation Research (SBIR) Phase II grant on August 29, 2019. This builds on a $225,000 Phase […]

Editas Medicine and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Cell Medicines

CAMBRIDGE, Mass., and GAITHERSBURG, Md., – October 7, 2019:– Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, and MaxCyte, Inc., the global cell-based therapies and life sciences company, today announced a new clinical and commercial license agreement. Editas Medicine will use MaxCyte’s Flow Electroporation® technology and ExPERT™ instruments for the advancement of engineered cell […]

KaloCyte Relocates to Downtown Baltimore as Co-Founders Join University of Maryland Faculty

Biotechnology Company Is Developing Synthetic Blood Product for Use in Trauma Settings BALTIMORE, Sept. 23, 2019 /PRNewswire/ — KaloCyte, a preclinical-stage healthcare biotechnology company developing a synthetic, bio-inspired red blood cell substitute for use in settings when stored red blood cells are not available, has joined Baltimore’s growing biotech community as a University of Maryland […]

Facility Logix Highlights Firm’s Significant Growth as It Celebrates 15th Anniversary

National Biotech Facility Consulting Firm Continues to Gain Traction in Milestone Year on Heels of Recent Project Completion for United Therapeutics and Academic Medical Center in the Southeast Burtonsville, MD – September 19, 2019 – Facility Logix, a life sciences consulting firm providing best-in-class customized facility solutions and novel approaches to facility design, real estate construction and project […]

PressComm

News